Literature DB >> 17521238

Effective isolation and culture of endothelial cells in embryoid body differentiated from human embryonic stem cells.

Jumi Kim1, Sung-Hwan Moon, Soo-Hong Lee, Dong-Ryul Lee, Gou-Young Koh, Hyung-Min Chung.   

Abstract

We describe the isolation of endothelial cells from the center region of the attached embryoid body (EB) by a two-step enzyme treatment. The isolated cells from the center and outgrowth region of the EB were characterized separately. As human embryonic stem (hES) cells differentiated in EB, they lost expression of the undifferentiated marker Oct-4, whereas expression levels of endothelial-specific markers were increased. Using RT-PCR, fluorescence-activated cell sorting (FACS) analysis, and immunofluorescence, we have shown that various endothelial cell markers, including platelet/endothelial cell adhesion molecule (PECAM), von Willebrand factor (vWF), Flk-1, and Tie2, were expressed on the attached EB. Compared with the outgrowth region of EB, the center region had a higher population of cells with these endothelial cell markers. Once isolated by the twostep enzyme treatment, cells from the center region continued to differentiate into endothelial cell lineage while expression level of endothelial cell markers in cells from the outgrowth region decreased in subcultures. This study has demonstrated that the isolation of EB by a two-step enzyme treatment is a useful technique to obtain endothelial cell marker-positive cells with high yield. Furthermore, a similar approach can be taken to identify the location and distribution of specific cell types in EB and thereby allow us to isolate and expand specific cell types.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17521238     DOI: 10.1089/scd.2006.0108

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  8 in total

1.  Discovery and characterization of novel microRNAs during endothelial differentiation of human embryonic stem cells.

Authors:  Jung Ki Yoo; Jumi Kim; Seong-Jun Choi; Hye Min Noh; Young Do Kwon; Hanna Yoo; Hyo Seon Yi; Hyung Min Chung; Jin Kyeoung Kim
Journal:  Stem Cells Dev       Date:  2012-02-07       Impact factor: 3.272

Review 2.  Engineering Strategies for the Formation of Embryoid Bodies from Human Pluripotent Stem Cells.

Authors:  Giuseppe Pettinato; Xuejun Wen; Ning Zhang
Journal:  Stem Cells Dev       Date:  2015-06-02       Impact factor: 3.272

3.  Gene expression profiles in CHA3 and CHA4 human embryonic stem cells and embryoid bodies.

Authors:  Sung-Hwan Moon; Sung-Whan Kim; Jong Soo Kim; Soon-Jung Park; Jeong Tae Do; Dong Ryul Lee; Hyung-Min Chung
Journal:  Mol Cells       Date:  2011-02-22       Impact factor: 5.034

Review 4.  Differentiation of hESCs into Mesodermal Subtypes: Vascular-, Hematopoietic- and Mesenchymal-lineage Cells.

Authors:  Sung-Hwan Moon; Jung Mo Kim; Ki-Sung Hong; Jeong Min Shin; Jumi Kim; Hyung-Min Chung
Journal:  Int J Stem Cells       Date:  2011-06       Impact factor: 2.500

5.  Delivery of small interfering RNA for inhibition of endothelial cell apoptosis by hypoxia and serum deprivation.

Authors:  Seung-Woo Cho; Lauren Hartle; Sun Mi Son; Fan Yang; Michael Goldberg; Qiaobing Xu; Robert Langer; Daniel G Anderson
Journal:  Biochem Biophys Res Commun       Date:  2008-08-31       Impact factor: 3.575

Review 6.  Strategies for derivation of endothelial lineages from human stem cells.

Authors:  Min Xu; Jiacai He; Chengfei Zhang; Jianguang Xu; Yuanyin Wang
Journal:  Stem Cell Res Ther       Date:  2019-07-08       Impact factor: 6.832

Review 7.  Recent Advances on Cell-Based Co-Culture Strategies for Prevascularization in Tissue Engineering.

Authors:  Sepehr Shafiee; Siavash Shariatzadeh; Ali Zafari; Alireza Majd; Hassan Niknejad
Journal:  Front Bioeng Biotechnol       Date:  2021-11-25

Review 8.  iPSC-Derived Liver Organoids: A Journey from Drug Screening, to Disease Modeling, Arriving to Regenerative Medicine.

Authors:  Cristina Olgasi; Alessia Cucci; Antonia Follenzi
Journal:  Int J Mol Sci       Date:  2020-08-27       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.